Avelumab in First-line NSCLC (JAVELIN Lung 100)

Clinical trial NCT02576574 · COMPLETED

Trial details

NCT number: NCT02576574
Sponsor: EMD Serono Research & Development Institute, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

First Line Non-Small Cell Lung Cancer

Start date: 2015-10-29
Primary completion: 2021-12-06
Enrollment: 1214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.